Healthequity Stock Buy Hold or Sell Recommendation

HQY
 Stock
  

USD 63.63  0.89  1.42%   

Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Healthequity is 'Strong Hold'. Macroaxis provides Healthequity buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding HQY positions. The advice algorithm takes into account all of Healthequity's available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Healthequity's buy-and-hold perspective. Please check Healthequity Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Healthequity and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Healthequity.

Execute Healthequity Buy or Sell Advice

The Healthequity recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Healthequity. Macroaxis does not own or have any residual interests in Healthequity or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Healthequity's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell HealthequityBuy Healthequity
Strong Hold

Volatility

Details

Hype Condition

Details

Current Valuation

Details

Odds of Distress

Details

Economic Sensitivity

Details

Analyst Consensus

Details

Financial Strenth (F Score)

Details

Financial Leverage

Inapplicable
Details

Reporting Quality (M-Score)

Details
For the selected time horizon Healthequity has a Risk Adjusted Performance of 0.029, Jensen Alpha of 0.0249, Total Risk Alpha of (0.040035), Sortino Ratio of 0.0064 and Treynor Ratio of 0.064
Macroaxis provides unbiased trade recommendations on Healthequity that should be used to complement current analysts and expert consensus on Healthequity. Our advice engine determines the entity's potential to grow exclusively from the perspective of an investors' current risk tolerance and investing horizon. To make sure Healthequity is not overpriced, please check out all Healthequity fundamentals, including its shares owned by insiders, total debt, retained earnings, as well as the relationship between the revenue and earnings per share . Given that Healthequity has a number of shares shorted of 3.95 M, we strongly advise you to confirm Healthequity market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Healthequity Trading Alerts and Improvement Suggestions

The company reported the last year's revenue of 795.07 M. Reported Net Loss for the year was (62.15 M) with profit before taxes, overhead, and interest of 423.71 M.
Healthequity has a poor financial position based on the latest SEC disclosures
Latest headline from news.google.com: Siemens Healthineers, Atrium Health Enter Multi-Year Value Partnership to Improve Health Care Capabilities, Access and Equity - Yahoo Finance

Healthequity current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Healthequity analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Healthequity analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price80.64
Target Median Price80.00
Target High Price104.00
Recommendation Mean1.70
Number Of Analyst Opinions14
Target Low Price68.00
Average Consensus Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Healthequity Returns Distribution Density

The distribution of Healthequity's historical returns is an attempt to chart the uncertainty of Healthequity's future price movements. The chart of the probability distribution of Healthequity stock daily returns describes the distribution of returns around its average expected value. We use Healthequity price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Healthequity returns is essential to provide solid investment advice for Healthequity.
Mean Return0.06Value At Risk-4.05
Potential Upside4.21Standard Deviation2.88
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Healthequity historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Healthequity Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Healthequity is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Healthequity backward and forwards among themselves. Healthequity's institutional investor refers to the entity that pools money to purchase Healthequity's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares10.4 K636 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares11.2 K756 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares11.2 K496 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares7.8 K506 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares7.8 K629 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares8.3 K562 K
Zurcher Kantonalbank Zurich CantonalbankCommon SharesK631 K
Note, although Healthequity's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Healthequity Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(15.84 M)(13.85 M)(32.94 M)(64.59 M)(71.62 M)(73.5 M)
Depreciation Amortization and Accretion15.95 M18.18 M55.35 M115.9 M137.19 M148.02 M
Net Cash Flow or Change in Cash and Cash Equivalents59.52 M162 M(169.75 M)137.08 M(103.39 M)(106.11 M)
Issuance Purchase of Equity Shares14.56 M22.93 M469.84 M295.35 M466.39 M503.21 M
Net Cash Flow from Financing14.56 M22.93 M1.47 B52.42 M394.86 M426.04 M
Net Cash Flow from Investing(36.75 M)25.65 M(1.74 B)(96.96 M)(639.25 M)(656.07 M)
Net Cash Flow Investment Acquisitions and Disposals(483 K)40.69 M(53.84 M)2.37 M2.13 M2.3 M
Net Cash Flow from Operations81.7 M113.42 M105.01 M181.62 M141 M152.13 M
Share Based Compensation14.31 M21.06 M39.84 M42.86 M52.75 M56.91 M

Healthequity Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Healthequity or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Healthequity's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Healthequity stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
0.024933
β
Beta against DOW0.82
σ
Overall volatility
2.72
Ir
Information ratio 0.0066

Healthequity Volatility Alert

Healthequity currently demonstrates below-average downside deviation. It has Information Ratio of 0.01 and Jensen Alpha of 0.02. However, we advise investors to further question Healthequity expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Healthequity's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Healthequity's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Healthequity Fundamentals Vs Peers

Comparing Healthequity's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Healthequity's direct or indirect competition across all of the common fundamentals between Healthequity and the related equities. This way, we can detect undervalued stocks with similar characteristics as Healthequity or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Healthequity's fundamental indicators could also be used in its relative valuation, which is a method of valuing Healthequity by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Healthequity to competition
FundamentalsHealthequityPeer Average
Return On Equity(3.34) %(0.31) %
Return On Asset0.39 %(0.14) %
Profit Margin(7.82) %(1.27) %
Operating Margin2.43 %(5.51) %
Current Valuation7.23 B16.62 B
Shares Outstanding83.6 M571.82 M
Shares Owned by Insiders1.97 %10.09 %
Shares Owned by Institutions103.07 %39.21 %
Number of Shares Shorted3.95 M4.71 M
Price to Earning525.29 X28.72 X
Price to Book3.50 X9.51 X
Price to Sales6.57 X11.42 X
Revenue795.07 M9.43 B
Gross Profit423.71 M27.38 B
EBITDA171.88 M3.9 B
Net Income(62.15 M)570.98 M
Cash and Equivalents176.89 M2.7 B
Cash per Share2.09 X5.01 X
Total Debt1000 M5.32 B
Debt to Equity0.54 %48.70 %
Current Ratio2.46 X2.16 X
Book Value Per Share17.87 X1.93 K
Cash Flow from Operations120.06 M971.22 M
Short Ratio4.56 X4.00 X
Earnings Per Share0.12 X3.12 X
Price to Earnings To Growth2.47 X4.89 X
Number of Employees3.69 K18.84 K
Beta0.83-0.15
Market Capitalization5.23 B19.03 B
Total Asset219.79 M29.47 B
Retained Earnings228.21 M9.33 B
Working Capital130.94 M1.48 B
Current Asset143.05 M9.34 B
   Exercise or conversion by Larry Trittschuh of 6419 shares of Healthequity subject to Rule 16b-3 [view details]

Healthequity Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Healthequity . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Healthequity Buy or Sell Advice

When is the right time to buy or sell Healthequity? Buying financial instruments such as Healthequity Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 (projected)
Receivables87.43 M94.33 M
Inventories193.5 K292.37 K

Use Investing Ideas to Build Portfolios

In addition to having Healthequity in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Utilities Thematic Idea Now

Utilities
Utilities Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Utilities theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities Theme or any other thematic opportunities.
View All  Next Launch
Please check Healthequity Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.96) 
Market Capitalization
5.3 B
Quarterly Revenue Growth YOY
0.09
Return On Assets
0.0039
Return On Equity
(0.0334) 
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.